Starfire Investment Advisers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Starfire Investment Advisers's PFE Position: Q2 2020 in Review
Starfire Investment Advisers increased its Pfizer (PFE) stake by 7.3% in Q2 2020, buying an estimated $79.4K and bringing the position to 34,457 shares worth $1.07M. The position accounts for 0.51% of the portfolio, ranked #52.
Starfire Investment Advisers first reported a position in PFE in Q1 2015 and has held it in 22 quarters since. The position peaked at $1.41M in Q4 2018. 2,443 funds tracked by Wall St. Rank hold PFE as of Q2 2020.
- Starfire Investment Advisers held 34,457 shares of Pfizer worth $1.07M as of Q2 2020.
- Starfire Investment Advisers bought 2,337 Pfizer shares in Q2 2020, an estimated $79.4K.
- Pfizer made up 0.51% of Starfire Investment Advisers's portfolio in Q2 2020, its #52 holding.
- Starfire Investment Advisers first reported a position in Pfizer in Q1 2015 and has held it in 22 quarters since.
- Starfire Investment Advisers's Pfizer position peaked at $1.41M in Q4 2018.
- 2,443 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.
Based on Starfire Investment Advisers's 13F filing for Q2 2020, filed 9 Jul 2020.